{"product_id":"total-artificial-heart-running-expenses","title":"What Are Operating Costs For Total Artificial Heart Program?","description":"\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"line_top\"\u003e\u003c\/div\u003e\n\u003ch2\u003eTotal Artificial Heart Program Running Costs\u003c\/h2\u003e\n\u003cp\u003eRunning a Total Artificial Heart Program demands substantial fixed overhead and high variable costs, driven by specialized staff and device procurement Expect initial monthly fixed costs around \u003cstrong\u003e$371,000\u003c\/strong\u003e, covering facility leases, insurance, and core administrative wages in 2026 Variable costs, including the TAH device and surgical kits, account for about \u003cstrong\u003e205%\u003c\/strong\u003e of revenue While the program achieves break-even quickly (1 month), the initial capital expenditure (CapEx) leads to a minimum cash requirement of \u003cstrong\u003e$3387 million\u003c\/strong\u003e by June 2026 You must secure this working capital to cover the ramp-up period before revenue stabilizes\n\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\" id=\"main_article_image\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003ch2\u003e\n\u003cspan style=\"color: #6067F2;\"\u003e7 Operational Expenses to Run \u003c\/span\u003eTotal Artificial Heart Program\u003c\/h2\u003e\u003cbr\u003e\n\u003ctable id=\"dwnld_tbl_id\"\u003e\n\u003ctr\u003e\n\u003cth\u003e#\u003c\/th\u003e\n\u003cth\u003eOperating Expense\u003c\/th\u003e\n\u003cth\u003eExpense Category\u003c\/th\u003e\n\u003cth\u003eDescription\u003c\/th\u003e\n\u003cth\u003eMin Monthly Amount\u003c\/th\u003e\n\u003cth\u003eMax Monthly Amount\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e1\u003c\/td\u003e\n\u003ctd\u003eStaff Payroll\u003c\/td\u003e\n\u003ctd\u003eWages\u003c\/td\u003e\n\u003ctd\u003eCore administrative and leadership wages total $145,416 monthly.\u003c\/td\u003e\n\u003ctd\u003e$145,416\u003c\/td\u003e\n\u003ctd\u003e$145,416\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e2\u003c\/td\u003e\n\u003ctd\u003eFacility Lease\u003c\/td\u003e\n\u003ctd\u003eFacility Fixed Cost\u003c\/td\u003e\n\u003ctd\u003eSpecialized Facility Lease is the single largest fixed operating expense at $120,000 per month.\u003c\/td\u003e\n\u003ctd\u003e$120,000\u003c\/td\u003e\n\u003ctd\u003e$120,000\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e3\u003c\/td\u003e\n\u003ctd\u003eDevice COGS\u003c\/td\u003e\n\u003ctd\u003eVariable Cost\u003c\/td\u003e\n\u003ctd\u003eTAH Device and Surgical Kits represent 150% of procedure revenue.\u003c\/td\u003e\n\u003ctd\u003e$0\u003c\/td\u003e\n\u003ctd\u003e$0\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e4\u003c\/td\u003e\n\u003ctd\u003eMalpractice Insurance\u003c\/td\u003e\n\u003ctd\u003eRisk Management\u003c\/td\u003e\n\u003ctd\u003eMedical Malpractice Insurance is budgeted at $45,000 monthly for the high-risk program.\u003c\/td\u003e\n\u003ctd\u003e$45,000\u003c\/td\u003e\n\u003ctd\u003e$45,000\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e5\u003c\/td\u003e\n\u003ctd\u003eFDA Compliance\u003c\/td\u003e\n\u003ctd\u003eRegulatory Overhead\u003c\/td\u003e\n\u003ctd\u003eMaintaining regulatory approval requires a fixed monthly budget of $15,000 for compliance.\u003c\/td\u003e\n\u003ctd\u003e$15,000\u003c\/td\u003e\n\u003ctd\u003e$15,000\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e6\u003c\/td\u003e\n\u003ctd\u003eEHR Licensing\u003c\/td\u003e\n\u003ctd\u003eTechnology Licensing\u003c\/td\u003e\n\u003ctd\u003eEHR and Remote Monitoring Licensing costs $8,500 monthly for patient data management.\u003c\/td\u003e\n\u003ctd\u003e$8,500\u003c\/td\u003e\n\u003ctd\u003e$8,500\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e7\u003c\/td\u003e\n\u003ctd\u003ePhysician Outreach\u003c\/td\u003e\n\u003ctd\u003eBusiness Development\u003c\/td\u003e\n\u003ctd\u003eMarketing and Physician Outreach is budgeted at $25,000 monthly to secure referrals.\u003c\/td\u003e\n\u003ctd\u003e$25,000\u003c\/td\u003e\n\u003ctd\u003e$25,000\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003c\/td\u003e\n\u003ctd\u003eTotal\u003c\/td\u003e\n\u003ctd\u003eAll Operating Expenses\u003c\/td\u003e\n\u003ctd\u003e\u003c\/td\u003e\n\u003ctd\u003e$358,916\u003c\/td\u003e\n\u003ctd\u003e$358,916\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/table\u003e\n\u003cdiv class=\"dwnld_btn_div\"\u003e\u003cbutton id=\"dwnld_btn_id\" class=\"dwnld_btn_clss\"\u003eDownload Table in XLSX\u003c\/button\u003e\u003c\/div\u003e\u003cbr\u003e\u003cbr\u003e\u003cbr\u003e\u003ch2\u003e\u003cspan style=\"color: #126CFF;\"\u003eWhat is the total required monthly operating budget for the first 12 months?\n\u003c\/span\u003e\u003c\/h2\u003e\n\u003cp\u003eThe total required monthly operating budget for the Total Artificial Heart Program starts with a \u003cstrong\u003e$371k\u003c\/strong\u003e fixed cost floor, but the \u003cstrong\u003e205%\u003c\/strong\u003e variable cost structure means revenue must immediately outpace costs to avoid hitting the projected \u003cstrong\u003e$3,387M\u003c\/strong\u003e cash low point, which you can read more about here: \u003ca href=\"\/blogs\/how-much-makes\/total-artificial-heart\"\u003eHow Much Does An Owner Make From Total Artificial Heart Program?\u003c\/a\u003e Honestly, that variable cost ratio is the biggest immediate red flag you'll face in the first 12 months.\u003c\/p\u003e\n\u003cdiv class=\"container_2_clmn_row\"\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-colons-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eFixed Cost Baseline\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eStaff and overhead fixed costs are \u003cstrong\u003e$371,000\u003c\/strong\u003e per month.\u003c\/li\u003e\n\u003cli\u003eThis is your minimum operational burn rate.\u003c\/li\u003e\n\u003cli\u003eIt covers essential, non-volume-dependent expenses.\u003c\/li\u003e\n\u003cli\u003eYou defintely need 12 months of this covered upfront.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-intro-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eVariable Cost Risk\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eVariable costs are projected at \u003cstrong\u003e205% of revenue\u003c\/strong\u003e.\u003c\/li\u003e\n\u003cli\u003eThis implies that for every dollar earned, you spend $2.05.\u003c\/li\u003e\n\u003cli\u003eThis structure requires massive gross margins on procedures.\u003c\/li\u003e\n\u003cli\u003eThe cash low point estimate is \u003cstrong\u003e$3,387M\u003c\/strong\u003e.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003ch2\u003e\u003cspan style=\"color: #126CFF;\"\u003eWhich cost categories represent the largest recurring monthly expenses?\n\u003c\/span\u003e\u003c\/h2\u003e\n\u003cp\u003eThe largest recurring expenses for the Total Artificial Heart Program are clearly the specialized facility lease, medical malpractice insurance, and the cost of the devices; understanding how to manage these levers is key, so review \u003ca href=\"\/blogs\/kpi-metrics\/total-artificial-heart\"\u003eWhat Are The 5 KPIs For Total Artificial Heart Program?\u003c\/a\u003e for performance tracking.\u003c\/p\u003e\n\u003cdiv class=\"container_2_clmn_row\"\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-intro-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eFixed Overhead Hitters\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eThe specialized facility lease is a huge fixed cost at \u003cstrong\u003e$120,000 per month\u003c\/strong\u003e.\u003c\/li\u003e\n\u003cli\u003eMedical malpractice insurance is defintely the second largest fixed drain, running \u003cstrong\u003e$45,000 monthly\u003c\/strong\u003e.\u003c\/li\u003e\n\u003cli\u003eThese two items alone account for \u003cstrong\u003e$165,000\u003c\/strong\u003e in overhead before treating one patient.\u003c\/li\u003e\n\u003cli\u003eYou must secure high utilization in that specialized space to cover this baseline.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-colons-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eThe Margin Killer\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eThe Total Artificial Heart (TAH) device Cost of Goods Sold (COGS) is the biggest variable threat.\u003c\/li\u003e\n\u003cli\u003eDevice COGS hits \u003cstrong\u003e120% of revenue\u003c\/strong\u003e, meaning you lose money on every procedure performed.\u003c\/li\u003e\n\u003cli\u003eThis negative gross margin requires immediate action on procurement or pricing structure.\u003c\/li\u003e\n\u003cli\u003eIf revenue is $500k, device costs are \u003cstrong\u003e$600k\u003c\/strong\u003e, creating an immediate $100k operational hole.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003ch2\u003e\u003cspan style=\"color: #126CFF;\"\u003eHow much working capital is needed to cover operations before positive cash flow?\n\u003c\/span\u003e\u003c\/h2\u003e\n\u003cp\u003eThe Total Artificial Heart Program needs \u003cstrong\u003e$3387M\u003c\/strong\u003e in minimum cash to sustain operations until collections and capital expenditure (CapEx) deployment stabilizes, projecting this runway requirement through \u003cstrong\u003eJune 2026\u003c\/strong\u003e; understanding how to manage this period is crucial, as detailed in resources covering metrics like \u003ca href=\"\/blogs\/kpi-metrics\/total-artificial-heart\"\u003eWhat Are The 5 KPIs For Total Artificial Heart Program?\u003c\/a\u003e\u003c\/p\u003e\n\u003cdiv class=\"container_2_clmn_row\"\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-colons-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eRequired Cash Buffer\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eMinimum cash required is \u003cstrong\u003e$3387M\u003c\/strong\u003e.\u003c\/li\u003e\n\u003cli\u003eThis covers the operational burn rate.\u003c\/li\u003e\n\u003cli\u003eStabilization date targeted for \u003cstrong\u003eJune 2026\u003c\/strong\u003e.\u003c\/li\u003e\n\u003cli\u003eCrucial to cover costs before collections arrive.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-intro-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eOperational Coverage\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eFunds specialized surgical implantation costs.\u003c\/li\u003e\n\u003cli\u003eCovers ongoing device management fees.\u003c\/li\u003e\n\u003cli\u003eDefintely supports multidisciplinary team salaries.\u003c\/li\u003e\n\u003cli\u003eEnsures patient care continuity regardless of payment lag.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003ch2\u003e\u003cspan style=\"color: #126CFF;\"\u003eIf procedure volume is 50% below forecast, how will we cover fixed overhead?\n\u003c\/span\u003e\u003c\/h2\u003e\n\u003cp\u003eIf procedure volume for the Total Artificial Heart Program falls 50% below forecast, you will immediately face a substantial operating cash shortfall against the \u003cstrong\u003e$371k\u003c\/strong\u003e fixed overhead, making the initial \u003cstrong\u003e15-month\u003c\/strong\u003e payback goal defintely unattainable without drastic action.\u003c\/p\u003e\n\u003cdiv class=\"container_2_clmn_row\"\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-intro-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eCovering the Fixed Cost Gap\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eFixed overhead stands at \u003cstrong\u003e$371,000\u003c\/strong\u003e monthly.\u003c\/li\u003e\n\u003cli\u003eA 50% volume reduction cuts variable revenue by half.\u003c\/li\u003e\n\u003cli\u003eYou must cover the entire fixed cost plus the lost contribution margin.\u003c\/li\u003e\n\u003cli\u003eIf variable contribution margin is \u003cstrong\u003e55%\u003c\/strong\u003e, the monthly shortfall is about \u003cstrong\u003e$102k\u003c\/strong\u003e.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-colons-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003ePayback Period Extension\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eThe 15-month payback relies on hitting forecast contribution targets.\u003c\/li\u003e\n\u003cli\u003eThis volume drop forces a complete re-evaluation of capital recovery timing.\u003c\/li\u003e\n\u003cli\u003eAction needed: aggressively reduce controllable operating expenses immediately.\u003c\/li\u003e\n\u003cli\u003eExplore strategies to boost utilization rates to recover lost ground, see \u003ca href=\"\/blogs\/profitability\/total-artificial-heart\"\u003eHow Increase Profitability Of Total Artificial Heart Program?\u003c\/a\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\u003cbr\u003e\u003cdiv class=\"card_smpl\"\u003e\n\n\u003cdiv class=\"double_border\"\u003e\n\n\u003cdiv class=\"card_smpl_header\"\u003e\n\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-plus-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\n\u003ch3\u003eKey Takeaways\u003c\/h3\u003e\n\n\u003c\/div\u003e\n\n\u003cul class=\"lst_crct_blog\"\u003e\n\n\u003cli\u003eThe total baseline monthly fixed and administrative overhead for the Total Artificial Heart Program is projected to be approximately $371,000 in 2026.\u003c\/li\u003e\n\n\u003cli\u003eVariable costs associated with the TAH device and surgical kits are extremely high, consuming 205% of procedure revenue.\u003c\/li\u003e\n\n\u003cli\u003eTo sustain operations through the initial ramp-up phase until revenue stabilizes, a minimum working capital requirement of $3.387 million must be secured.\u003c\/li\u003e\n\n\u003cli\u003eDespite the heavy initial investment and high overhead, the program is modeled to achieve payback on its investment within 15 months.\u003c\/li\u003e\n\n\u003c\/ul\u003e\n\n\u003c\/div\u003e\n\n\u003c\/div\u003e\u003cbr\u003e\u003cbr\u003e\n\u003ch2\u003eRunning Cost 1\n: \u003cspan style=\"color: #126CFF;\"\u003eStaff Payroll\n\u003c\/span\u003e\n\u003c\/h2\u003e\u003cbr\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-colons-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eCore Leadership Pay\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eCore leadership and administrative payroll hits \u003cstrong\u003e$145,416 monthly\u003c\/strong\u003e in 2026. This fixed cost covers essential high-level roles needed to run a specialized center of excellence for Total Artificial Heart procedures. This number is a baseline expense you must cover before any revenue comes in.\u003c\/p\u003e\n\u003c\/div\u003e\u003cbr\u003e\u003cdiv class=\"container_2_clmn_row\"\u003e\n\u003cdiv class=\"card_smpl_2\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-tips-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eFixed Wage Breakdown\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eThis \u003cstrong\u003e$145,416\u003c\/strong\u003e monthly payroll is a fixed operating cost for 2026. It covers the Medical Director at \u003cstrong\u003e$45,833\/mo\u003c\/strong\u003e and the Chief Surgical Officer at \u003cstrong\u003e$62,500\/mo\u003c\/strong\u003e, plus necessary support staff wages. This is a foundational expense required regardless of patient volume.\u003c\/p\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eMedical Director: $45,833\/mo\u003c\/li\u003e\n\u003cli\u003eCSO: $62,500\/mo\u003c\/li\u003e\n\u003cli\u003eSupport staff wages included.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-intro-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eManaging Executive Burden\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eHigh fixed salaries demand high utilization to justify the expense. Avoid hiring support staff defintely before they're needed; use fractional expertise for initial admin needs. If the Medical Director and CSO aren't fully utilized, the cost-to-serve per procedure spikes fast.\u003c\/p\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eTie bonuses to procedure volume targets.\u003c\/li\u003e\n\u003cli\u003eUse fractional roles initially where possible.\u003c\/li\u003e\n\u003cli\u003eEnsure utilization covers the \u003cstrong\u003e$108,333\u003c\/strong\u003e executive base.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\u003cdiv class=\"card_smpl\"\u003e\u003cdiv class=\"double_border\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-pin-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003ePayroll vs. Procedure Volume\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eThe executive team alone costs \u003cstrong\u003e$108,333\u003c\/strong\u003e monthly. To cover just this portion with a 50% gross margin goal, you need roughly $216,666 in procedure revenue just for these two roles. Plan your initial procedure throughput carefully to absorb this fixed cost.\u003c\/p\u003e\n\u003c\/div\u003e\u003c\/div\u003e\u003cbr\u003e\u003cbr\u003e\n\u003ch2\u003eRunning Cost 2\n: \u003cspan style=\"color: #126CFF;\"\u003eFacility Lease\n\u003c\/span\u003e\n\u003c\/h2\u003e\u003cbr\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-colons-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eLease Weight\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eThe specialized facility lease for the Total Artificial Heart Program is your biggest fixed overhead, hitting \u003cstrong\u003e$120,000 monthly\u003c\/strong\u003e. This figure doesn't even include the extra costs for utilities or specialized equipment upkeep, so watch those add-ons closely. This is a massive, non-negotiable cost base to clear.\u003c\/p\u003e\n\u003c\/div\u003e\u003cbr\u003e\u003cdiv class=\"container_2_clmn_row\"\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-tips-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eLease Inputs\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eThis \u003cstrong\u003e$120k\u003c\/strong\u003e covers the dedicated surgical suite and long-term patient management space required for TAH procedures. To model this accurately, you need the signed lease terms, including escalation clauses and any amortization schedules for required build-outs. It's a huge fixed cost that must be covered before you see profit.\u003c\/p\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eSigned lease agreement terms.\u003c\/li\u003e\n\u003cli\u003eMonthly rent figure: \u003cstrong\u003e$120,000\u003c\/strong\u003e.\u003c\/li\u003e\n\u003cli\u003eFactor in utility\/maintenance buffers.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"card_smpl_2\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-intro-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eManaging Fixed Space\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eSince this expense is fixed, reducing it means negotiating better upfront terms or finding a smaller initial footprint for the specialized center. A common mistake is signing a long lease requiring massive tenant improvements you can't easily exit. Defintely push hard for tenant improvement allowances to offset initial capital outlay.\u003c\/p\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eNegotiate tenant improvement credits.\u003c\/li\u003e\n\u003cli\u003ePhase facility expansion plans carefully.\u003c\/li\u003e\n\u003cli\u003eEnsure exit clauses are favorable.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\u003cdiv class=\"card_smpl\"\u003e\u003cdiv class=\"double_border\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-pin-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eBreak-Even Driver\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eBecause the lease is \u003cstrong\u003e$120,000\u003c\/strong\u003e fixed, your break-even point is heavily dictated by utilization rates. Your payroll costs are actually higher at $145,416 monthly, so facility cost alone means you need high procedure density just to cover the building before you pay your leadership team.\u003c\/p\u003e\n\u003c\/div\u003e\u003c\/div\u003e\u003cbr\u003e\u003cbr\u003e\n\u003ch2\u003eRunning Cost 3\n: \u003cspan style=\"color: #126CFF;\"\u003eDevice COGS\n\u003c\/span\u003e\n\u003c\/h2\u003e\u003cbr\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-colons-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eUnsustainable COGS\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eYour device cost structure is unsustainable right now. In 2026, the combined cost of the TAH device, kits, and consumables hits \u003cstrong\u003e150%\u003c\/strong\u003e of procedure revenue. This means every procedure booked loses money before factoring in fixed overhead.\u003c\/p\u003e\n\u003c\/div\u003e\u003cbr\u003e\u003cdiv class=\"container_2_clmn_row\"\u003e\n\u003cdiv class=\"card_smpl_2\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-tips-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eDevice Cost Breakdown\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eThis \u003cstrong\u003e150%\u003c\/strong\u003e figure is derived from two main buckets tied directly to volume. The TAH device and surgical kits alone cost \u003cstrong\u003e120%\u003c\/strong\u003e of procedure revenue. Specialized consumables add another \u003cstrong\u003e30%\u003c\/strong\u003e on top of that. You need firm quotes for the device and kits to validate the \u003cstrong\u003e120%\u003c\/strong\u003e assumption, as this is the primary driver.\u003c\/p\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eTAH Device \u0026amp; Kits: \u003cstrong\u003e120%\u003c\/strong\u003e of procedure revenue.\u003c\/li\u003e\n\u003cli\u003eConsumables: An additional \u003cstrong\u003e30%\u003c\/strong\u003e margin cost.\u003c\/li\u003e\n\u003cli\u003eTotal COGS: \u003cstrong\u003e150%\u003c\/strong\u003e of revenue.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-intro-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eCutting Device Costs\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eYou can't operate profitably with COGS at 150% of revenue; this requires immediate negotiation. Focus on securing better pricing tiers for the core TAH device, perhaps by committing to a minimum volume over three years. Also, review if the \u003cstrong\u003e30%\u003c\/strong\u003e consumable cost can be reduced by using approved, lower-cost alternatives for non-critical items. Defintely push for volume discounts.\u003c\/p\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eNegotiate device pricing based on projected volume.\u003c\/li\u003e\n\u003cli\u003eAudit consumable usage for waste or overstocking.\u003c\/li\u003e\n\u003cli\u003eTarget a COGS reduction below \u003cstrong\u003e100%\u003c\/strong\u003e immediately.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\u003cdiv class=\"card_smpl\"\u003e\u003cdiv class=\"double_border\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-pin-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eProfitability Hurdle\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eThe \u003cstrong\u003e150%\u003c\/strong\u003e COGS means that even if your fixed costs were zero-no payroll, no lease-you would still lose 50 cents for every dollar of procedure revenue booked. This cost structure must be addressed before scaling any patient volume. It's a hard stop.\u003c\/p\u003e\n\u003c\/div\u003e\u003c\/div\u003e\u003cbr\u003e\u003cbr\u003e\n\u003ch2\u003eRunning Cost 4\n: \u003cspan style=\"color: #126CFF;\"\u003eMalpractice Insurance\n\u003c\/span\u003e\n\u003c\/h2\u003e\u003cbr\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-colons-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eInsurance Cost Set\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eMalpractice insurance is a fixed operating expense of \u003cstrong\u003e$45,000\u003c\/strong\u003e monthly for the specialized heart program. This cost directly reflects the inherent, high-stakes risk associated with Total Artificial Heart implantation and management.\u003c\/p\u003e\n\u003c\/div\u003e\u003cbr\u003e\u003cdiv class=\"container_2_clmn_row\"\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-tips-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eFixed Cost Breakdown\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eThis \u003cstrong\u003e$45,000\/month\u003c\/strong\u003e premium is a non-negotiable fixed operating expense, unlike variable costs like Device COGS (150% of revenue). You must budget this amount monthly, regardless of patient volume, because it covers liability for high-acuity procedures like TAH implantation. If the program scales to 10 patients a month, this cost remains static.\u003c\/p\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eFixed monthly premium.\u003c\/li\u003e\n\u003cli\u003eCovers TAH liability risk.\u003c\/li\u003e\n\u003cli\u003eBudgeted for 2026 operations.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"card_smpl_2\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-intro-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eManaging Insurance Spend\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eSince this is fixed, savings come from negotiating policy terms, not reducing volume. Avoid common mistakes like underinsuring, which invites catastrophic risk given the $120,000 facility lease and high payroll. You might explore multi-year commitments for a potential \u003cstrong\u003e5% discount\u003c\/strong\u003e, but never compromise coverage limits for this critical area.\u003c\/p\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eNegotiate multi-year terms.\u003c\/li\u003e\n\u003cli\u003eBenchmark against similar centers.\u003c\/li\u003e\n\u003cli\u003eDo not lower coverage limits.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\u003cdiv class=\"card_smpl\"\u003e\u003cdiv class=\"double_border\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-pin-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eRisk Profile Impact\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eThe \u003cstrong\u003e$45,000\u003c\/strong\u003e premium signals the market's perception of the Total Artificial Heart Program's risk. This number is significantly higher than general cardiology coverage due to the complexity and novelty of the procedures performed. It's a necessary expense for operating in this specialized space.\u003c\/p\u003e\n\u003c\/div\u003e\u003c\/div\u003e\u003cbr\u003e\u003cbr\u003e\n\u003ch2\u003eRunning Cost 5\n: \u003cspan style=\"color: #126CFF;\"\u003eFDA Compliance\n\u003c\/span\u003e\n\u003c\/h2\u003e\u003cbr\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-colons-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eFixed Regulatory Cost\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eYou must budget \u003cstrong\u003e$15,000 monthly\u003c\/strong\u003e just to keep the Total Artificial Heart Program compliant with the Food and Drug Administration (FDA). This covers ongoing Quality Monitoring activities necessary to maintain your device approvals. This fixed operating expense is non-negotiable for market access, period.\u003c\/p\u003e\n\u003c\/div\u003e\u003cbr\u003e\u003cdiv class=\"container_2_clmn_row\"\u003e\n\u003cdiv class=\"card_smpl_2\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-tips-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eCompliance Budget Breakdown\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eThis \u003cstrong\u003e$15,000\u003c\/strong\u003e covers the necessary overhead for regulatory adherence, separate from initial device COGS. It's a fixed cost, meaning it doesn't change based on patient volume, unlike the \u003cstrong\u003e150%\u003c\/strong\u003e Device COGS figure. You need this budget locked in monthly to avoid operational shutdowns.\u003c\/p\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eCovers Quality Monitoring costs.\u003c\/li\u003e\n\u003cli\u003eFixed monthly overhead component.\u003c\/li\u003e\n\u003cli\u003eEssential for maintaining device approval.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-intro-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eManaging Compliance Spend\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eYou can't cut this cost without risking approval, but you can manage how you spend it. Avoid using expensive external consultants for routine monitoring if internal staff can handle standard reporting. A common mistake is underestimating the time needed for documentation audits, which drives up consulting fees.\u003c\/p\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eInternalize routine reporting tasks.\u003c\/li\u003e\n\u003cli\u003eBenchmark compliance staff utilization.\u003c\/li\u003e\n\u003cli\u003eAudit documentation processes yearly.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\u003cdiv class=\"card_smpl\"\u003e\u003cdiv class=\"double_border\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-pin-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eRegulatory Risk Check\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eIf you miss this \u003cstrong\u003e$15,000\u003c\/strong\u003e payment, you stop monitoring quality, which immediately triggers a regulatory risk event. This cost is small compared to the \u003cstrong\u003e$45,000\u003c\/strong\u003e Malpractice Insurance, but failure here stops all revenue generation dead. Don't treat compliance as optional overhead, it's the license to operate.\u003c\/p\u003e\n\u003c\/div\u003e\u003c\/div\u003e\u003cbr\u003e\u003cbr\u003e\n\u003ch2\u003eRunning Cost 6\n: \u003cspan style=\"color: #126CFF;\"\u003eEHR Licensing\n\u003c\/span\u003e\n\u003c\/h2\u003e\u003cbr\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-colons-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eLicensing Spend\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eThe monthly cost for necessary patient data systems is fixed. You must budget \u003cstrong\u003e$8,500 per month\u003c\/strong\u003e for Electronic Health Record (EHR) and remote monitoring licensing to support post-operative care protocols. This cost is non-negotiable for compliance and continuity.\u003c\/p\u003e\n\u003c\/div\u003e\u003cbr\u003e\u003cdiv class=\"container_2_clmn_row\"\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-tips-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eData System Cost\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eThis \u003cstrong\u003e$8,500\u003c\/strong\u003e monthly fee covers the software infrastructure required for continuous patient oversight. It bundles EHR access with remote monitoring tools essential for tracking implanted device function post-surgery. This is a fixed operating expense, not tied to procedure volume.\u003c\/p\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eCovers \u003cstrong\u003eEHR\u003c\/strong\u003e access.\u003c\/li\u003e\n\u003cli\u003eIncludes \u003cstrong\u003eRemote Monitoring\u003c\/strong\u003e tools.\u003c\/li\u003e\n\u003cli\u003eFixed at \u003cstrong\u003e$8,500\/month\u003c\/strong\u003e.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"card_smpl_2\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-intro-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eManage Licensing\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eLicensing costs are sticky but can be optimized before signing multi-year agreements. Check if bundled pricing for the EHR and remote monitoring platform offers discounts for volume commitments beyond the first year. You should defintely not pay for unused user seats.\u003c\/p\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eNegotiate multi-year terms.\u003c\/li\u003e\n\u003cli\u003eAudit active user licenses.\u003c\/li\u003e\n\u003cli\u003eCheck for platform bundling deals.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\u003cdiv class=\"card_smpl\"\u003e\u003cdiv class=\"double_border\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-pin-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eCompliance Check\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eIf you scale patient volume rapidly, ensure your existing \u003cstrong\u003e$8,500\u003c\/strong\u003e license tier supports the increased data load without triggering expensive, immediate upgrades. Unexpected scaling fees kill contribution margins fast.\u003c\/p\u003e\n\u003c\/div\u003e\u003c\/div\u003e\u003cbr\u003e\u003cbr\u003e\n\u003ch2\u003eRunning Cost 7\n: \u003cspan style=\"color: #126CFF;\"\u003ePhysician Outreach\n\u003c\/span\u003e\n\u003c\/h2\u003e\u003cbr\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-colons-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eOutreach Budget Reality\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003ePhysician outreach costs \u003cstrong\u003e$25,000 monthly\u003c\/strong\u003e to drive referrals into your Total Artificial Heart Program. This expense is crucial for building trust with referring cardiologists and surgeons. Without consistent outreach, patient volume stalls, making it impossible to cover your high fixed costs like the \u003cstrong\u003e$120,000\u003c\/strong\u003e facility lease. \u003c\/p\u003e\n\u003c\/div\u003e\u003cbr\u003e\u003cdiv class=\"container_2_clmn_row\"\u003e\n\u003cdiv class=\"card_smpl_2\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-tips-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eReferral Spend Inputs\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eThis \u003cstrong\u003e$25,000\u003c\/strong\u003e budget funds activities designed to reach referring physicians and hospital systems. It covers marketing materials, travel for relationship building, and potentially hiring a dedicated liaison. Compared to the \u003cstrong\u003e$145,416\u003c\/strong\u003e payroll or \u003cstrong\u003e$120,000\u003c\/strong\u003e lease, it's a manageable spend necessary for patient acquisition. \u003c\/p\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eCovers referral development costs.\u003c\/li\u003e\n\u003cli\u003eSupports community reputation building.\u003c\/li\u003e\n\u003cli\u003eEssential for patient pipeline flow.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-intro-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eManaging Referral Costs\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eYou must track the Cost Per Qualified Referral (CPQR) generated by this spend. Avoid broad advertising; focus resources on high-yield interactions, like sponsoring specific surgical society meetings. If travel costs balloon, consider virtual engagement first. Honestly, if you don't track ROI, this $25k is defintely a sunk cost. \u003c\/p\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eTrack Cost Per Qualified Referral.\u003c\/li\u003e\n\u003cli\u003ePrioritize direct physician engagement.\u003c\/li\u003e\n\u003cli\u003eBenchmark against industry standards.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\u003cdiv class=\"card_smpl\"\u003e\u003cdiv class=\"double_border\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-pin-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eOutreach vs. Device Costs\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eRemember, your Device COGS alone is \u003cstrong\u003e150% of procedure revenue\u003c\/strong\u003e. Therefore, every patient secured via outreach must be high-value and ideally progress quickly through the treatment pathway. This outreach spend is a prerequisite for revenue that must cover massive upfront device costs and \u003cstrong\u003e$45,000\u003c\/strong\u003e in malpractice insurance. \u003c\/p\u003e\n\u003c\/div\u003e\u003c\/div\u003e\u003cbr\u003e\u003cbr\u003e\u003cbr\u003e","brand":"FinancialModelsLab","offers":[{"title":"Default Title","offer_id":49304461770995,"sku":"total-artificial-heart-running-expenses","price":0.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0522\/6191\/2762\/files\/total-artificial-heart-running-expenses.webp?v=1782694031","url":"https:\/\/financialmodelslab.com\/products\/total-artificial-heart-running-expenses","provider":"Financial Models Lab","version":"1.0","type":"link"}